Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Idera and Merck KGaA collaborate on development of TLR9 agonists for cancer

Dec. 20, 2007

Actelion reports preliminary data from bosentan proof-of-concept cancer study

Dec. 20, 2007

GlaxoSmithKline exercises option to further develop and commercialize Exelixis' XL-880

Dec. 20, 2007

T cells expressing costimulatory ligands, a novel approach in cancer immunotherapy

Dec. 20, 2007

Anti-KIR monoclonal antibody enhances NK cell killing activity in vitro and in vivo

Dec. 20, 2007

IDM Pharma provides update on development of mifamurtide, Uvidem and IDM-2101

Dec. 20, 2007

Cleveland BioLabs reports positive results from mouse study of CBLB-612

Dec. 20, 2007

Phase I studies of AVE-9633, AVE-1642 reported

Dec. 20, 2007

Novel oncolytic drugs revealed in recent patent literature

Dec. 20, 2007

Philippine Bureau of Food and Drugs grants product registration for Epeius' Rexin-G

Dec. 19, 2007

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...